Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4

Clinical trial NCT02473146 · COMPLETED

Trial details

NCT number: NCT02473146
Sponsor: Versailles Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2015-11-18
Primary completion: 2021-02-26
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.